Allos Therapeutics, Inc.

210 articles about Allos Therapeutics, Inc.

• Allos Therapeutics, Inc. to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematology Annual Meeting

  12/3/2009

• Allos Therapeutics, Inc. Announces Issuance of U.S. Patent for FOLOTYN

  11/30/2009

• Allos Therapeutics, Inc. Announces New Data on FOLOTYN(TM) to be Presented at the American Society of Hematology Meeting

  11/11/2009

• Allos Therapeutics, Inc. to Present at Upcoming Conferences in November

  11/10/2009

• Allos Therapeutics, Inc. Reports Third Quarter 2009 Financial Results

  11/4/2009

• New Jersey Continues to Attract Pharma Industry, LEO Pharma, Allos Therapeutics, Inc., Dendreon Corporation and More

  10/26/2009

• Allos Therapeutics, Inc. to Report Third Quarter 2009 Results on November 3, 2009

  10/26/2009

• Allos Therapeutics, Inc. Announces Closing of Public Offering

  10/14/2009

• Allos Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock

  10/7/2009

• Allos Therapeutics, Inc. Announces U.S. Availability of FOLOTYN(TM) (pralatrexate injection) for Relapsed or Refractory Peripheral T-Cell Lymphoma

  10/5/2009

• Allos Therapeutics, Inc. Cancer Drug Gets FDA Nod

  9/25/2009

• US FDA Panel Backs Allos Therapeutics, Inc.'s Lymphoma Drug

  9/3/2009

• US FDA Staff Question Allos Therapeutics, Inc. Lymphoma Drug Data

  9/1/2009

• Allos Therapeutics, Inc. to Hold Post Advisory Committee Conference Call

  9/1/2009

• Allos Therapeutics, Inc. Announces FDA Advisory Committee to Review Pralatrexate for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

  8/10/2009

• Allos Therapeutics, Inc. Reports Second Quarter 2009 Financial Results

  8/5/2009

• Allos Therapeutics, Inc. Launches Peripheral T-Cell Lymphoma Website

  7/23/2009

• Allos Therapeutics, Inc. to Report Second Quarter 2009 Results on August 4, 2009

  7/22/2009

• Allos Therapeutics, Inc. Completes Enrollment in Randomized Phase 2b Trial of Pralatrexate in Patients with Advanced Non-Small Cell Lung Cancer

  7/7/2009

• Allos Therapeutics, Inc. to Present at the 8th Annual Needham Life Sciences Conference

  6/3/2009